WuXi Biologics (Cayman) (FRA:1FW2) Institutional Ownership : 39.86% (As of May. 14, 2024)

View and export this data going back to 2017. Start your Free Trial

What is WuXi Biologics (Cayman) Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, WuXi Biologics (Cayman)'s institutional ownership is 39.86%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, WuXi Biologics (Cayman)'s Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, WuXi Biologics (Cayman)'s Float Percentage Of Total Shares Outstanding is 0.00%.

WuXi Biologics (Cayman) Institutional Ownership Historical Data

The historical data trend for WuXi Biologics (Cayman)'s Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi Biologics (Cayman) Institutional Ownership Chart

WuXi Biologics (Cayman) Historical Data

The historical data trend for WuXi Biologics (Cayman) can be seen below:

	2023-06-30	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31
Institutional Ownership	44.60	45.17	45.80	46.82	47.06	47.55	45.46	45.19	44.14	39.86

WuXi Biologics (Cayman) Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

WuXi Biologics (Cayman) (FRA:1FW2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WuXi Biologics (Cayman) Inc (FRA:1FW2) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

WXIBF:USA WXXWY:USA 2269:Mexico 02269:Hong Kong 1FW1:Germany

Address

No. 108, Meiliang Road, Mashan Binhu District, Wuxi, CHN, 214092

Website

https://www.wuxibiologics.com

WuXi Biologics is one of the largest global biologics CRDMOs. WuXi Biologics, incorporated in 2014 following the reorganization of WuXi PharmaTech, later known as WuXi AppTec, now has global revenue of CNY 15 billion. North American represented 55.6% of total revenue in 2022. It adopts the follow and win the molecule strategy by providing end-to-end services, from drug discovery to commercial manufacturing. It also adopts a global dual-sourcing strategy by providing drug products and large-scale drug substance manufacturing.

WuXi Biologics (Cayman) (FRA:1FW2) Headlines

No Headlines